Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Olympus Corporation

Market Cap 1,748B 10.84B 9.45B 8.75B 8.2B 15.37B 1,023B 15.46B 104B 40.25B 504B 40.69B 39.82B P/E 2026
24.3x
P/E 2027 * 18.1x
Enterprise Value 1,760B 10.91B 9.52B 8.81B 8.25B 15.47B 1,030B 15.57B 105B 40.52B 507B 40.97B 40.09B EV / Sales 2026
1.67x
EV / Sales 2027 * 1.71x
Free-Float
94.53%
Yield 2026
2.02%
Yield 2027 * 1.87%
1 day+3.10%
1 week-3.46%
Current month-7.03%
1 month-11.35%
3 months+22.74%
6 months-18.85%
Current year-18.63%
1 week 10
Extreme 10
10.74
1 month 10
Extreme 10
11.81
Current year 8.08
Extreme 8.08
13.55
1 year 8.08
Extreme 8.08
13.73
3 years 8.08
Extreme 8.08
19.69
5 years 8.08
Extreme 8.08
74.99
10 years 6.26
Extreme 6.2625
74.99
Manager TitleAgeSince
Chief Executive Officer 63 01/06/2025
Director of Finance/CFO 58 01/04/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 01/04/2023
Director/Board Member 41 01/06/2019
Director/Board Member 63 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+3.10%-3.46% - - 10.84B
+0.63%-1.01%+16.77%-11.66% 173B
+1.14%-1.04%-20.14%+25.65% 144B
-0.33%-1.63%-9.79%-25.47% 125B
+0.76%-3.45%-55.29%-16.07% 67.32B
+0.78%+2.64%+18.33%-4.09% 50.3B
-0.58%-1.16%-25.96%-32.70% 43.8B
+2.20%-2.14%+9.95%+7.38% 35.89B
-0.44%-0.03%+3.74%+34.39% 34.9B
+0.72%-5.51%-13.59%-22.65% 28.02B
Average +0.88%-1.86%-8.44%-5.02% 78.04B
Weighted average by Cap. +0.63%-1.89%-7.21%-4.84%

Financials

2026 2027 *
Net sales 998B 6.19B 5.4B 5B 4.68B 8.78B 584B 8.83B 59.31B 22.99B 288B 23.24B 22.74B 1,065B 6.6B 5.76B 5.33B 4.99B 9.36B 623B 9.42B 63.27B 24.52B 307B 24.79B 24.26B
Net income 56.48B 350M 305M 283M 265M 497M 33.05B 500M 3.35B 1.3B 16.27B 1.31B 1.29B 98.47B 611M 532M 493M 462M 866M 57.62B 871M 5.85B 2.27B 28.36B 2.29B 2.24B
Net Debt 11.66B 72.33M 63.06M 58.4M 54.67M 103M 6.82B 103M 693M 269M 3.36B 271M 266M 69.9B 433M 378M 350M 328M 615M 40.9B 618M 4.15B 1.61B 20.13B 1.63B 1.59B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
29,297
Date Price Change Volume
18/06/26 10.31 $ +3.10% 48,928
17/06/26 10.00 $ -3.38% 38,600
16/06/26 10.35 $ -0.10% 66,106
15/06/26 10.36 $ -3.00% 69,822
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,646.00JPY
Average target price
1,897.69JPY
Spread / Average Target
+15.29%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!